Approval Audited financial Results
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archean Chemical Industries reported a weak FY25 with standalone revenue from operations falling to Rs. 1,013.79 crore from Rs. 1,329.58 crore last year, a drop of about 24%. Standalone profit after tax (PAT) plunged to Rs. 184.92 crore from Rs. 322.35 crore, down roughly 43%, mainly due to a one-time exceptional charge of Rs. 40.18 crore and lower operating income. EBITDA margins also shrank year-on-year. Q4 FY25 was relatively stable with revenue of Rs. 321.77 crore and PAT of Rs. 58.31 crore. The board recommended a final dividend of Rs. 1.50 per share (75%) and reappointed the same statutory auditor, PKF Sridhar & Santhanam LLP, which issued an unmodified (clean) opinion on the results. HVS & Associates was appointed as the new Secretarial Auditor for five years.
Sharply lower revenue and profit, along with margin compression, signal a tough year for shareholders and may weigh on near-term stock sentiment, though the clean audit, dividend payout, and continued strategic investments in semiconductor and energy storage businesses offer some positives for long-term investors.